| Year | Title | Author(s) |
| 2014 |
Tetraspanins as regulators of the tumour microenvironment: implications for metastasis and therapeut 171(24): 5462-5490 |
Detchokul, S Williams, ED Parker, MW Frauman, AG |
| 2014 |
Synthesis, Structure-Activity Relationships and Brain Uptake of a Novel Series of Benzopyran Inhibit 57(4): 1368-1377 |
Mountford, SJ Albiston, AL Charman, WN Ng, L Holien, JK Parker, MW Nicolazzo, JA Thompson, PE Chai, SY |
| 2014 |
PPAR delta activation attenuates hepatic steatosis in Ldlr(-/-) mice by enhanced fat oxidation, redu 55(7): 1254-1266 |
Bojic, LA Telford, DE Fullerton, MD Ford, RJ Sutherland, BG Edwards, JY Sawyez, CG Gros, R Kemp, BE Steinberg, GR Huff, MW |
| 2014 |
A Systematic and Functional Classification of Streptococcus pyogenes That Serves as a New Tool for M 210(8): 1325-1338 |
Sanderson-Smith, M De Oliveira, DMP Guglielmini, J McMillan, DJ Vu, T Holien, JK Henningham, A Steer, AC Bessen, DE Dale, JB Curtis, N Beall, BW Walker, MJ Parker, MW Carapetis, JR Van Melderen, L Sriprakash, KS Smeesters, PR |
| 2014 |
Decline in calcitonin receptor expression in osteocytes with age 221(2): 181-191 |
Gooi, JH Chia, LY Walsh, NC Karsdal, MA Quinn, JMW Martin, TJ Sims, NA |
| 2014 |
gp130 in late osteoblasts and osteocytes is required for PTH-induced osteoblast differentiation 223(2): 181-190 |
Standal, T Johnson, RW McGregor, NE Poulton, IJ Ho, PWM Martin, TJ Sims, NA |
| 2014 |
The Primary Function of gp130 Signaling in Osteoblasts Is To Maintain Bone Formation and Strength, R 29(6): 1492-1505 |
Johnson, RW Brennan, HJ Vrahnas, C Poulton, IJ McGregor, NE Standal, T Walker, EC Koh, TT Nguyen, H Walsh, NC Forwood, MR Martin, TJ Sims, NA |
| 2014 |
Aliskiren Reduces Myocardial Ischemia-Reperfusion Injury by a Bradykinin B-2 Receptor- and Angiotens 63(4): 768-773 |
Koid, SS Ziogas, J Campbell, DJ |
| 2014 |
Mechanism of Activation of Protein Kinase JAK2 by the Growth Hormone Receptor 344(6185): 710-+ |
Brooks, AJ Dai, W O’Mara, ML Abankwa, D Chhabra, Y Pelekanos, RA Gardon, O Tunny, KA Blucher, KM Morton, CJ Parker, MW Sierecki, E Gambin, Y Gomez, GA Alexandrov, K Wilson, IA Doxastakis, M Mark, AE Waters, MJ |
| 2014 |
Structural Studies of Streptococcus pyogenes Streptolysin O Provide Insights into the Early Steps of 426(4): 785-792 |
Feil, SC Ascher, DB Kuiper, MJ Tweten, RK Parker, MW |
| 2014 |
Oncostatin M acting via OSMR, augments the actions of IL-1 and TNF in synovial fibroblasts 68(2): 101-109 |
Le Goff, B Singbrant, S Tonkin, BA Martin, TJ Romas, E Sims, NA Walsh, NC |
| 2014 |
The Architecture and Evolution of Cancer Neochromosomes 26(5): 653-667 |
Garsed, DW Marshall, OJ Corbin, VDA Hsu, A Di Stefano, L Schroder, J Li, J Feng, ZP Kim, BW Kowarsky, M Lansdell, B Brookwell, R Myklebost, O Meza-Zepeda, L Holloway, AJ Pedeutour, F Choo, KHA Damore, MA Deans, AJ Papenfuss, AT Thomas, DM |
| 2014 |
Crystallization and preliminary X-ray diffraction analysis of the interleukin-3 alpha receptor bound 70(): 358-361 |
Broughton, SE Hercus, TR Nero, TL Dhagat, U Owczarek, CM Hardy, MP Fabri, LJ Scotney, PD Nash, AD Wilson, NJ Lopez, AF Parker, MW |
| 2014 |
Do current therapeutic anti-A beta antibodies for Alzheimer’s disease engage the target? 127(6): 803-810 |
Watt, AD Crespi, GAN Down, RA Ascher, DB Gunn, A Perez, KA McLean, CA Villemagne, VL Parker, MW Barnham, KJ Miles, LA |
| 2014 |
Crystallization and preliminary X-ray diffraction analysis of the Fab portion of the Alzheimer’s dis 70(Pt 3):374-7 |
Crespi, GAN Ascher, DB Parker, MW Miles, LA |
Page 4 of 6 pages ‹ First < 2 3 4 5 6 >